Rachel Masch, MD, MPH

Locations

Family Planning Office

Silver Building, 5th Floor, 281 First Avenue (First Avenue at 16th Street), New York, NY, 10003

212-844-5570

Insurance Information

Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Scopus h-index:16

Article:29

Review Article:4

Comment/Debate:1

Letter:1

Chapter:1

Recent Artifacts

• Safety and Acceptability of Three Ablation Treatments for High-Grade Cervical Precancer: Early Data From a Randomized Noninferiority Clinical Trial
• Cervical Cancer Prevention in El Salvador: Gains to Date and Challenges for the Future
• Thermal Ablation Treatment for Cervical Precancer (Cervical Intraepithelial Neoplasia Grade 2 or Higher [CIN2+])
• Multisite clinical validation of isothermal amplification-based SARS-CoV-2 detection assays using different sampling strategies
• Removing global barriers to cervical cancer prevention and moving towards elimination
• Cervical Cancer Screening in Low- And Middle-Income Countries
• Cervical Cancer Screening with Human Papillomavirus Self-Sampling among Transgender Men in El Salvador
• The cost-effectiveness of human papillomavirus self-collection among cervical cancer screening non-attenders in El Salvador
• Outcomes for step-wise implementation of a human papillomavirus testing-based cervical screen-and-treat program in El Salvador
• Evaluation of two alternative ablation treatments for cervical pre-cancer against standard gas-based cryotherapy: A randomized non-inferiority study

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Masch during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.